News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,462 Results
Type
Article (58590)
Company Profile (217)
Press Release (662640)
Multimedia
Podcasts (113)
Webinars (27)
Section
Business (199073)
Career Advice (2111)
Deals (33177)
Drug Delivery (110)
Drug Development (77461)
Employer Resources (151)
FDA (15397)
Job Trends (14289)
News (330180)
Policy (27227)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2874)
Academic (1)
Accelerated approval (49)
ADA (41)
Adcomms (21)
Allergies (159)
Alliances (51036)
ALS (217)
Alzheimer's disease (1801)
Antibody-drug conjugate (ADC) (511)
Approvals (15843)
Artificial intelligence (747)
ASCO (308)
Autoimmune disease (317)
Automation (62)
Bankruptcy (294)
Best Places to Work (11162)
BIOSECURE Act (20)
Biosimilars (198)
Biotechnology (137)
Bladder cancer (198)
Brain cancer (73)
Breast cancer (731)
Cancer (6026)
Cardiovascular disease (446)
Career advice (1830)
Career pathing (45)
CAR-T (337)
CDC (39)
Celiac Disease (2)
Cell therapy (899)
Cervical cancer (47)
Clinical research (67089)
Collaboration (2248)
Company closure (5)
Compensation (1017)
Complete response letters (73)
COVID-19 (2525)
CRISPR (108)
C-suite (1225)
Cystic fibrosis (148)
Data (8009)
Decentralized trials (3)
Denatured (37)
Depression (158)
Dermatology (82)
Diabetes (578)
Diagnostics (6773)
Digital health (59)
Diversity (9)
Diversity, equity & inclusion (37)
Drug discovery (352)
Drug pricing (167)
Drug shortages (19)
Duchenne muscular dystrophy (263)
Earnings (84369)
Editorial (67)
Employer branding (19)
Employer resources (135)
Events (111310)
Executive appointments (1147)
FDA (19094)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1788)
Gene editing (219)
Generative AI (61)
Gene therapy (690)
GLP-1 (944)
Government (3514)
Grass and pollen (6)
Guidances (409)
Healthcare (17974)
Hematology (165)
HIV (76)
Huntington's disease (55)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (103)
Immunology and inflammation (244)
Immuno-oncology (100)
Indications (195)
Infectious disease (2860)
Inflammatory bowel disease (204)
Inflation Reduction Act (15)
Influenza (125)
Intellectual property (299)
Interviews (379)
IPO (14910)
IRA (45)
Job creations (3438)
Job search strategy (1547)
JPM (59)
Kidney cancer (16)
Labor market (97)
Layoffs (526)
Leadership (41)
Legal (5936)
Liver cancer (99)
Longevity (32)
Lung cancer (861)
Lymphoma (431)
Machine learning (62)
Management (53)
Manufacturing (1053)
MASH (196)
Medical device (13654)
Medtech (13796)
Mergers & acquisitions (19509)
Metabolic disorders (1400)
mRNA (218)
Multiple sclerosis (190)
NASH (15)
Neurodegenerative disease (428)
Neuropsychiatric disorders (99)
Neuroscience (3336)
Neurotech (1)
NextGen: Class of 2026 (6112)
Non-profit (4449)
Now hiring (65)
Obesity (584)
Opinion (309)
Ovarian cancer (233)
Pain (249)
Pancreatic cancer (323)
Parkinson's disease (385)
Partnered (35)
Patents (570)
Patient recruitment (689)
Peanut (56)
People (60693)
Pharmaceutical (50)
Pharmacy benefit managers (25)
Phase 1 (21326)
Phase 2 (29298)
Phase 3 (21601)
Pipeline (9158)
Policy (292)
Postmarket research (2631)
Preclinical (9731)
Press Release (71)
Prostate cancer (323)
Psychedelics (46)
Radiopharmaceuticals (334)
Rare diseases (1066)
Real estate (6071)
Recruiting (65)
Regulatory (22937)
Reports (45)
Research institute (2697)
Resumes & cover letters (286)
Rett syndrome (42)
RNA editing (16)
RSV (78)
Schizophrenia (175)
Series A (290)
Series B (213)
Service/supplier (15)
Sickle cell disease (111)
Special edition (28)
Spinal muscular atrophy (159)
Sponsored (49)
Startups (3568)
State (1)
Stomach cancer (12)
Supply chain (117)
Tariffs (79)
The Weekly (74)
Vaccines (1044)
Venture capital (113)
Weight loss (362)
Women's health (123)
Worklife (20)
Date
Today (104)
Last 7 days (585)
Last 30 days (2910)
Last 365 days (28730)
2026 (13956)
2025 (28741)
2024 (33341)
2023 (38287)
2022 (49043)
2021 (53056)
2020 (51149)
2019 (44805)
2018 (33887)
2017 (31244)
2016 (31996)
2015 (38040)
2014 (29496)
2013 (25327)
2012 (29683)
2011 (29700)
2010 (29141)
Location
Africa (827)
Alabama (95)
Alaska (6)
Arizona (334)
Arkansas (15)
Asia (42464)
Australia (7186)
California (12615)
Canada (3636)
China (1489)
Colorado (555)
Connecticut (581)
Delaware (412)
Europe (98088)
Florida (1891)
Georgia (421)
Hawaii (3)
Idaho (62)
Illinois (1117)
India (89)
Indiana (607)
Iowa (23)
Japan (569)
Kansas (125)
Kentucky (35)
Louisiana (58)
Maine (85)
Maryland (1472)
Massachusetts (9064)
Michigan (380)
Minnesota (689)
Mississippi (7)
Missouri (148)
Montana (33)
Nebraska (26)
Nevada (149)
New Hampshire (88)
New Jersey (3494)
New Mexico (33)
New York (3514)
North Carolina (1742)
North Dakota (11)
Northern California (6268)
Ohio (389)
Oklahoma (24)
Oregon (40)
Pennsylvania (2332)
Puerto Rico (28)
Rhode Island (50)
South America (1147)
South Carolina (84)
South Dakota (1)
Southern California (5039)
Tennessee (212)
Texas (2027)
United States (45264)
Utah (330)
Vermont (1)
Virginia (322)
Washington D.C. (78)
Washington State (1087)
West Virginia (4)
Wisconsin (151)
Wyoming (2)
721,462 Results for "small business innovation research sbir".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Global Small Molecule Inhibitor Market to Hit USD 542.87 Billion by 2035 | CAGR 5.75% (2026–2035) – Towards Healthcare Research and Consulting
May 6, 2026
·
1 min read
Drug Development
Soaak Technologies Awarded Phase I Small Business Innovation Research (SBIR) Contract from the U.S. Air Force
Soaak Technologies, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Air Force (USAF) for 2023.
July 20, 2023
·
5 min read
Press Releases
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
March 23, 2026
·
6 min read
Press Releases
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Giuliana Rancic
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation in an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
February 1, 2026
·
3 min read
Press Releases
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas
June 1, 2026
·
2 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
May 13, 2026
·
4 min read
Funding
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
While peptides are currently the dominant approach to GLP-1 agonism, Ambrosia Biosciences is pursuing a small-molecule approach.
April 1, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
May 18, 2026
·
3 min read
Press Releases
Pershing Square Sohn Cancer Research Alliance Doubles Funding Commitment, Awarding 13 Innovators in Cancer Research
May 5, 2026
·
8 min read
1 of 72,147
Next
